Editorial Comment to Determining programmed cell death ligand 1 expression in circulating tumor cells of patients with clear cell renal cell carcinoma and its correlation with response to programmed cell death protein 1 inhibitors

Int J Urol. 2022 Sep;29(9):954-955. doi: 10.1111/iju.14893. Epub 2022 Apr 11.

Author

Taigo Kato¹

Affiliation

¹ Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.

PMID: 35411635
DOI: 10.1111/iju.14893

No abstract available

Publication types

Editorial
Comment

MeSH terms

Apoptosis
Carcinoma, Renal Cell* / drug therapy
Carcinoma, Renal Cell* / pathology
Humans
Immune Checkpoint Inhibitors
Kidney Neoplasms* / drug therapy
Kidney Neoplasms* / pathology
Ligands
Neoplastic Cells, Circulating*

Substances

Immune Checkpoint Inhibitors
Ligands